(Q49015926)

17 February 2018

title

Intravenous autologous bone marrow mononuclear cells for ischemic stroke. (English)

1 reference

17 February 2018

1 reference

Sean I Savitz

1

1 reference

17 February 2018

Vivek Misra

2

1 reference

17 February 2018

Mallik Kasam

3

1 reference

17 February 2018

Harrinder Juneja

4

1 reference

17 February 2018

Charles S Cox

5

1 reference

17 February 2018

Susan Alderman

6

1 reference

17 February 2018

Imo Aisiku

7

1 reference

17 February 2018

Siddhartha Kar

8

1 reference

17 February 2018

Adrian Gee

9

1 reference

17 February 2018

James C Grotta

10

1 reference

17 February 2018

publication date

1 July 2011

1 reference

17 February 2018

published in

Annals of Neurology

1 reference

17 February 2018

volume

70

1 reference

17 February 2018

issue

1

1 reference

17 February 2018

page(s)

59-69

1 reference

17 February 2018

Optimizing the success of cell transplantation therapy for stroke

cites work

1 reference

Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia

21 January 2018

1 reference

A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats

21 January 2018

1 reference

Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats.

21 January 2018

1 reference

Treatment with bone marrow mononuclear cells induces functional recovery and decreases neurodegeneration after sensorimotor cortical ischemia in rats.

21 January 2018

1 reference

Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis

21 January 2018

1 reference

Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children

21 January 2018

1 reference

Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke

21 January 2018

1 reference

Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experience.

21 January 2018

1 reference

Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke

21 January 2018

1 reference

Proof-of-principle phase II MRI studies in stroke: sample size estimates from dichotomous and continuous data.

21 January 2018

1 reference

Lesion volume change after treatment with tissue plasminogen activator can discriminate clinical responders from nonresponders

21 January 2018

1 reference

Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect

21 January 2018

1 reference

Marrow stromal cell transplantation in stroke and traumatic brain injury

21 January 2018

1 reference

Transplantation of cultured human neuronal cells for patients with stroke

21 January 2018

1 reference

Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial

21 January 2018

1 reference

Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study

21 January 2018

1 reference

Intravenous route of cell delivery for treatment of neurological disorders: a meta-analysis of preclinical results.

21 January 2018

1 reference

Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging.

21 January 2018

1 reference

Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.22458

1 reference

17 February 2018

PubMed ID

21786299

1 reference

17 February 2018